Literature DB >> 7894776

A truncated recombinant intercellular adhesion molecule-1 inhibits adhesion of leukemic cell lines to upregulated endothelial cells.

L Ross1, C M Davis, L Molony.   

Abstract

Intercellular adhesion molecule-1, a member of the immunoglobulin supergene family, is the ligand for the integrin lymphocyte function associated antigen-1. Intercellular adhesion molecule-1 and lymphocyte function associated antigen-1 binding interactions mediate leukocyte adherence and migration. Previous work has shown that the adherence of lymphocyte function associated antigen-1 is directed to the first immunoglobulinlike domain of the endothelial cell surface protein intracellular adhesion molecule-1. We have constructed a truncated intercellular adhesion molecule-1 gene encoding the first 185 amino acids from the amino terminus and overexpressed it in Escherichia coli. The recombinant protein was purified from insoluble inclusion bodies and refolded into an active conformation by a denaturation/renaturation cycle. The identity of the protein was confirmed by microsequencing and by Western blot analysis using a polyclonal antibody to ICAM-1. We have demonstrated that this soluble region of the otherwise membrane-bound ligand is an inhibitor of Molt or HL-60 cell adhesion to cytokine-stimulated endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7894776     DOI: 10.1007/bf02639398

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  20 in total

1.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

Authors:  J S Pober; M A Gimbrone; L A Lapierre; D L Mendrick; W Fiers; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

2.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Intercellular adhesion molecule 1 on liver allografts during rejection.

Authors:  D H Adams; S G Hubscher; J Shaw; R Rothlein; J M Neuberger
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

4.  Keratinocyte intercellular adhesion molecule-1 (ICAM-1) expression precedes dermal T lymphocytic infiltration in allergic contact dermatitis (Rhus dermatitis).

Authors:  C E Griffiths; B J Nickoloff
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1).

Authors:  S D Marlin; T A Springer
Journal:  Cell       Date:  1987-12-04       Impact factor: 41.582

7.  Endothelial-leukocyte adhesion molecule-1-dependent and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium.

Authors:  F W Luscinskas; A F Brock; M A Arnaout; M A Gimbrone
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

8.  E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro.

Authors:  J F Leeuwenberg; E F Smeets; J J Neefjes; M A Shaffer; T Cinek; T M Jeunhomme; T J Ahern; W A Buurman
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

9.  Analysis of expression and soluble form of intercellular adhesion molecule-1 in malignant melanoma.

Authors:  T Kageshita; A Yoshii; T Kimura; T Ono
Journal:  J Dermatol       Date:  1992-11       Impact factor: 4.005

10.  The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands.

Authors:  M S Diamond; J Garcia-Aguilar; J K Bickford; A L Corbi; T A Springer
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.